Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
:::
:::

SHChien

 

 

 

 

Sheng-Hsuan Chien, MD

Education

Medicine, Chung Shan medical university

Doctoral candidates, Institute of Clinical medicine, National Yang Ming Chia Tung University

Current Position

Attending physician, Division of Transfusion Medicine, Department of Medicine, Taipei Veterans General Hospital

Adjunct Physician of Division of Hematology, Department of medicine, Taipei Veterans General Hospital

Adjunct Associate Professor, National Yang Ming Chiao Tung University

Associate Professor, Department Education

Experiences

Chief resident of Division of Hematology and Oncology, Department of medicine, Taipei Veterans General Hospital

Attending physician of Division of Hematology and Oncology, Department of medicine, Taitung branch, Taipei Veterans General Hospital

Visiting Scholar of Cellular Immunotherapy Center in City of Hope

License

Board of Internal Medicine

Board of Hematology

Board of Oncology

Board of Hematopoietic stem cell transplantation

Medical Expertise

Hematology, Anemia, Platelet and coagulation disorders, Lymphoma, Leukemia, Myeloma, Hematopoietic stem cell transplantation

Language

Mandarin Taiwanese English

Publications

  1. Sheng-Hsuan Chien, Hsueng-Mei Liu, Po-Ming Chen, Po-Shen Ko, Jeong-Shi Lin, Ying-Ju Chen, Li-Hsuan Lee, Liang-Tsai Hsiao, Tzeon-Jye Chiou, Jyh-Pyng Gau, Muh-Hwa Yang, Chun-Yu Liu* The landscape of BCR-ABL mutations in patients with Philadelphia chromosome-positive leukaemias in the era of second-generation tyrosine kinase inhibitors. Hematological Oncology. 2020;38:390–398
  2. Xiuli Wang* , Ryan Urak , Miriam Walter , Min Guan , Tianxu Han , Vibhuti Vyas , Sheng-Hsuan Chien , Brenna Gittins , Mary C Clark , Sally Mokhtari , Angelo Cardoso , Don J Diamond , John Zaia , Stephen J Forman , Ryotaro Nakamura Large-scale manufacturing and characterization of CMV-CD19 CAR T cells J Immunother Cancer 2022 Jan;10(1):e003461.doi: 10.1136/jitc-2021-003461.
  3. Sheng-Hsuan Chien, Yao-Chung Liu, Chia-Jen Liu, Po-Shen Ko, Hao-Yuan Wang, Liang-Tsai Hsiao, Tzeon-Jye Chiou,Jin-Hwang Liu, Jyh-Pyng Gau*. Invasive mold infections in acute leukemia patients undergoing allogeneic hematopoietic stem cell transplantation. J Microbiol Immunol Infect. 2019 Dec;52(6):973-982
  4. Ibrahim Aldoss, Samer K. Khaled, Xiuli Wang, Joycelynne Palmer, Yan Wang, Jamie R. Wagner, Mary C. Clark, Jennifer Simpson, Jinny Paul, Vibhuti Vyas, Sheng-Hsuan Chien, Anthony Stein, Vinod Pullarkat, Amandeep Salhotra, Monzr M. Al Malki, Sandra H. Thomas, Lihua E. Budde, Guido Marcucci, Christine E. Brown1, Stephen J. Forman. Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T Cell Therapy in Adults with high-risk Relapsed/Refractory ALL. Clin Cancer Res 2023 Feb 16;29(4):742-753
  5. Sheng-Hsuan Chien, Ming Yao, Chi-Cheng Li, Ping-Ying Chang, Ming-Sun Yu, Cih-En Huang, Tran-Der Tan, Cheng-Hsien Lin, Su-Peng Yeh, Sin-syue Li, Po-Nan Wang, Yi-Chang Liu, Jyh-Pyng Gau *. Charlson comorbidity index predicts outcomes of elderly after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome. J Formos Med Assoc. 2021 Jan 8;S0929-6646(20)30621-5

Last Modified:

回到最上